Peri-operative Assessment
Risk, optimisation and medicines around surgery
A peri-operative medical opinion in three parts: a risk estimate built from named tools with their inputs shown, the conditions worth improving before the operation date, and a plan for each medicine before, on the day of and after the procedure. Testing follows the current ACC/AHA or ESC guideline, and the decision to proceed stays with the surgical and anaesthetic team and the patient.
Who it is for
- Pre-assessment clinic doctors and anaesthetists preparing patients for elective surgery
- Physicians and geriatricians asked for a peri-operative medical opinion
- Surgical residents and registrars admitting patients for urgent or emergency operations
What it does
Estimates risk with named tools
Applies the Revised Cardiac Risk Index or the NSQIP calculator for cardiac risk, ARISCAT for pulmonary complications, STOP-BANG for sleep apnoea, Caprini for venous thromboembolism and the Apfel score for post-operative nausea, showing every input.
Weighs functional capacity and frailty
Records functional capacity in metabolic equivalents or with the Duke Activity Status Index, grades ASA class and frailty, and sets them against the urgency and inherent risk of the planned procedure.
Orders only tests that change management
Decides on ECG, echocardiography, natriuretic peptides or stress testing by the ACC/AHA or ESC peri-operative guideline, recommending a test only when its result would change the plan and never at the cost of delaying urgent surgery.
Plans each medicine by day
Gives a before, day-of and after plan for anticoagulants by drug, kidney function and bleeding risk; antiplatelets by indication and stent date; and insulin, SGLT2 inhibitors, GLP-1 receptor agonists, steroids and antihypertensives.
Matches regional anaesthesia to the anticoagulant
Applies a named regional anaesthesia guideline to the drug and dose the patient actually takes, giving one clear interval before a spinal, epidural or deep block and before catheter removal.
Identifies what can be optimised
Picks out what is worth improving before the operation, such as iron deficiency anaemia, HbA1c, blood pressure, heart failure, asthma or COPD control, nutrition, smoking and alcohol use, and says what is realistic in the time available.
How it works
- The clinician gives the planned procedure and its urgency, the anaesthetic, the cardiac and respiratory history with functional capacity, the full medication list and recent results.
- The engine classifies the surgery by urgency and inherent risk, then assesses comorbidity, functional capacity and frailty.
- It calculates risk with named tools and decides which investigations, if any, would change management.
- It writes a medication plan for each relevant drug and a list of what to optimise before surgery.
- It adds points for the anaesthetist and a post-operative plan, followed by numbered references from PubMed and ClinicalTrials.gov and, for named medicines, US product labels from DailyMed.
What to include
- The procedure, its urgency and the planned anaesthetic
- Cardiac and respiratory history and functional capacity
- Medications, particularly anticoagulants, antiplatelets, insulin and steroids
- Blood results, ECG and any echo
Example cases
- 72M for elective hip replacement in 3 weeks: drug-eluting stent 4 months ago on aspirin and ticagrelor, eGFR 48. Plan?
- Type 2 diabetes on empagliflozin and basal insulin, for laparoscopic cholecystectomy on a morning list. Medication plan?
- AF on dabigatran, eGFR 38, for colonoscopy with polypectomy. When to stop and restart, and is bridging needed?
What the report contains
- Conclusion and Recommendation
- Risk Summary
- Before Surgery
- Medication Plan
- Intra-operative Considerations
- After Surgery
- Information Needed
- Key Evidence & References
Limits
- Whether to proceed, postpone or change the operation is decided by the surgeon, the anaesthetist and the patient. The engine estimates risk and plans care; it does not clear anyone for surgery.
- Risk calculators estimate population risk from the inputs typed and can mislead when data are missing or the procedure is unusual, and the engine cannot examine the patient or listen for a murmur.
- Drug labels attached are US labels, interruption intervals differ between national and society guidelines, and local anaesthetic, haematology and pre-assessment protocols take precedence.
Frequently asked questions
When should apixaban or rivaroxaban be stopped before surgery?
It depends on the bleeding risk of the procedure, kidney function and whether neuraxial anaesthesia is planned. The American College of Chest Physicians guideline and the PAUSE management protocol use standardised interruptions, shorter for low-bleeding-risk and longer for high-bleeding-risk procedures, without heparin bridging, and regional anaesthesia guidelines set their own intervals. The engine applies the named guideline to the patient's drug, dose and creatinine clearance.
Which patients need heparin bridging when warfarin is stopped for surgery?
The 2022 ACCP guideline suggests bridging for patients with a mechanical heart valve and suggests against it in atrial fibrillation and when venous thromboembolism is the only indication; a stroke or venous thromboembolism in the past three months calls for an individual plan. In atrial fibrillation, a randomised trial found that bridging increased bleeding without reducing arterial thromboembolism. The engine classifies thrombotic risk and states whether bridging is indicated.
Should aspirin be stopped before surgery in a patient with a coronary stent?
Usually not. Aspirin taken for secondary prevention is continued through most operations, and stopping dual antiplatelet therapy soon after a stent raises the risk of stent thrombosis, so elective surgery is often deferred. The exceptions are operations where bleeding in a closed space would be catastrophic, such as intracranial or spinal surgery. The engine plans antiplatelets by indication, stent type and date.
How long before surgery should an SGLT2 inhibitor be stopped?
SGLT2 inhibitors are stopped before surgery because of the risk of euglycaemic ketoacidosis. US product labels advise stopping them several days before scheduled surgery, with the interval set by agent, while some national guidelines advise a shorter omission. They are restarted only when the patient is eating and drinking normally. The engine gives the plan for the named drug and points out where local guidance differs.
Related articles
Clinical article
Anticoagulants and antiplatelets around surgery: stopping, bridging and restarting
A structured approach to anticoagulants and antiplatelets around surgery: bleeding risk, DOAC interruption, bridging, coronary stents and neuraxial blocks.
7 min read
Clinical article
Euglycaemic ketoacidosis with SGLT2 inhibitors: recognition and management
Recognising and treating euglycaemic diabetic ketoacidosis in patients on SGLT2 inhibitors: who is at risk, ketone testing, insulin with glucose, prevention.
7 min read
Guide
From patient intake form to consultation: starting with the history already taken
How Sana Health intake forms work, from a shared link to a consultation in any engine, and how to use a patient-completed history well and safely.
5 min read
Clinical article
Small bowel obstruction: who needs an operation tonight, and who can safely wait
Deciding between urgent surgery and non-operative care in small bowel obstruction: CT signs of strangulation, contrast studies and planned reassessment.
6 min read
Related engines
ACS, heart failure, arrhythmia and ECGs
Interactions, dose adjustment and monitoring
Glucose emergencies, insulin and hormones